Inbrain Pharma
Inbrain Pharma is a provider of therapeutic solutions for neurodegenerative diseases founded in 2018 by Matthieu Fisichella, David Devos and Caroline Moreau.
1
Funding Rounds
$2.0m
Money raised
Overview
Inbrain Pharma is a provider of therapeutic solutions for neurodegenerative diseases founded in 2018 by Matthieu Fisichella, David Devos and Caroline Moreau.
- Website:
- Headquarters: Lille
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma****** Fi******** |
|
- | |
| Da*** De*** |
|
- | - |
| Ca****** Mo**** |
|
- | - |
Funding series
Funding Series Analysis
The company Inbrain Pharma has raised a total of $2m in funding over 1 rounds.
Key Insights:
- Inbrain Pharma Seed Round, May 2025: $2m
Inbrain Pharma Seed Round, May 2025
$2m
Industries
Inbrain Pharma is active in the following industries: